Featured Articles

  1. How To Recruit 236 Patients In An Osteoarthritis Study On Time During The Peak Of The Pandemic 7/23/2024

    A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.

  2. Maximizing Efficiency In Data Management Services In A Breast Cancer Study 7/23/2024

    Learn how database validation, database lock, and the development of the electronic CRF were used in a HER2-positive operable breast cancer study.

  3. Top Countries For Rescuing Your Clinical Study 7/23/2024

    When your study is in trouble, choosing the right country can help get it back on track. While many countries can and should be considered, palleos healthcare discusses the countries they have experienced with regard to clinical trial rescue.

  4. Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic 7/23/2024

    How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.

  5. Meeting 100% Recruitment 7 Months Ahead Of Schedule 7/23/2024

    Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.

  6. Breaking Barriers In ED Treatment: A 100% Recruitment Success! 7/23/2024

    Discover how Palleos achieved full patient enrollment across four countries in record time in an Erectile Dysfunction study.

  7. Time-To-Event Analysis In Oncology Through The Prism Of Estimands 7/23/2024

    Considering an ICH E9R(1) Addendum on Estimands and Sensitivity Analysis, several sensitivity analyses are now regarded as supplementary analyses. Learn about these changes and their effects oncology trials.

  8. EU's New Clinical Trial Regulation: What Does It Hold For Sponsors And Sites? 7/23/2024

    The Clinical Trials Information System (CTIS) is a centralized platform for Clinical Trial Application (CTA) and marketing authorization submissions, and supervision of clinical trials across the European Union/European Economic Area (EU/EEA). The regulation, which came into effect on January 31, 2022, aims to simplify and streamline routine clinical processes.

  9. Are You An Emerging Biotech? Things To Consider When Selecting A CRO 7/22/2024

    Better understand how smaller biotech companies should approach CRO selection and what they should consider before launching their clinical development program.

  10. Racial Diversity In Trials: Clinical Findings, Challenges, And The Role Of CROs 7/22/2024

    Race and ethnic inclusion matter. When creating a clear picture of the safety and efficacy of a drug, uncover diversity's critical role in studies for providing clinically meaningful insights.